Subscribe To
Ocular therapeutix™ announces fda approval of supplemental new drug application (snda) for dextenza® (dexamethasone ophthalmic insert) 0.4 mg for intracanalicular use for the treatment of ocular itchi
BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical<...
October 11, 2021, 12:30 pm
Ocular therapeutix™ announces fda approval of supplemental new drug application (snda) for dextenza® (dexamethasone ophthalmic insert) 0.4 mg for intracanalicular use for the treatment of ocular itchi
BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical<...
October 11, 2021, 12:30 pm
Ocular therapeutix™ announces fda approval of supplemental new drug application (snda) for dextenza® (dexamethasone ophthalmic insert) 0.4 mg for intracanalicular use for the treatment of ocular itchi
BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical<...
October 11, 2021, 12:30 pm
Ocular therapeutix™ announces fda approval of supplemental new drug application (snda) for dextenza® (dexamethasone ophthalmic insert) 0.4 mg for intracanalicular use for the treatment of ocular itchi
BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical<...
October 11, 2021, 12:30 pm
Does verrica pharmaceuticals inc. (vrca) have the potential to rally 60% as wall street analysts expect?
The mean of analysts' price targets for Verrica pharmaceuticals Inc. (VRCA) points to a 59.8% upside in...
October 11, 2021, 12:17 pm
Does verrica pharmaceuticals inc. (vrca) have the potential to rally 60% as wall street analysts expect?
The mean of analysts' price targets for Verrica pharmaceuticals Inc. (VRCA) points to a 59.8% upside in...
October 11, 2021, 12:17 pm
Does verrica pharmaceuticals inc. (vrca) have the potential to rally 60% as wall street analysts expect?
The mean of analysts' price targets for Verrica pharmaceuticals Inc. (VRCA) points to a 59.8% upside in...
October 11, 2021, 12:17 pm
Adms stock soars 70% thanks to adamas pharmaceuticals acquisition news
ADMS stock is seeing huge gains this morning as it announces a planned merger with fellow biopharma company Supernus worth $400 million. The post ADMS...
October 11, 2021, 12:02 pm
Adms stock soars 70% thanks to adamas pharmaceuticals acquisition news
ADMS stock is seeing huge gains this morning as it announces a planned merger with fellow biopharma company Supernus worth $400 million. The post ADMS...
October 11, 2021, 12:02 pm
Adms stock soars 70% thanks to adamas pharmaceuticals acquisition news
ADMS stock is seeing huge gains this morning as it announces a planned merger with fellow biopharma company Supernus worth $400 million. The post ADMS...
October 11, 2021, 12:02 pm
Is pfizer stock a buy or sell after booster shot authorization?
Pfizer is one of the key leaders in the US pharmaceutical industry. The company has delivered huge succ...
October 11, 2021, 11:47 am
Is pfizer stock a buy or sell after booster shot authorization?
Pfizer is one of the key leaders in the US pharmaceutical industry. The company has delivered huge succ...
October 11, 2021, 11:47 am
Is pfizer stock a buy or sell after booster shot authorization?
Pfizer is one of the key leaders in the US pharmaceutical industry. The company has delivered huge succ...
October 11, 2021, 11:47 am
Adamas merger investigation: halper sadeh llp announces investigation into whether the sale of adamas pharmaceuticals, inc. is fair to shareholders; investors are encouraged to contact the firm – adms
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Adamas ...
October 11, 2021, 11:39 am
Adamas merger investigation: halper sadeh llp announces investigation into whether the sale of adamas pharmaceuticals, inc. is fair to shareholders; investors are encouraged to contact the firm – adms
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Adamas ...
October 11, 2021, 11:39 am
Adamas merger investigation: halper sadeh llp announces investigation into whether the sale of adamas pharmaceuticals, inc. is fair to shareholders; investors are encouraged to contact the firm – adms
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Adamas ...
October 11, 2021, 11:39 am
Tracon pharmaceuticals and china-based eucure biopharma strike partnership to develop clinical-stage ctla-4 antibody yh001
TRACON pharmaceuticals Inc. has entered into a collaborative partnership agreement with China-based Euc...
October 11, 2021, 8:55 am
Tracon pharmaceuticals and china-based eucure biopharma strike partnership to develop clinical-stage ctla-4 antibody yh001
TRACON pharmaceuticals Inc. has entered into a collaborative partnership agreement with China-based Euc...
October 11, 2021, 8:55 am
Tracon pharmaceuticals and china-based eucure biopharma strike partnership to develop clinical-stage ctla-4 antibody yh001
TRACON pharmaceuticals Inc. has entered into a collaborative partnership agreement with China-based Euc...
October 11, 2021, 8:55 am
Supernus bolsters parkinson's portfolio with $450m adamas buyout: highlights
Supernus pharmaceuticals Inc (NASDAQ: SUPN) has agreed to acquire Adamas ...
October 11, 2021, 8:53 am